A194 A POSSIBLE ASSOCIATION BETWEEN SECUKINUMAB AND NEW-ONSET INFLAMMATORY BOWEL DISEASE: A CASE SERIES

BACKGROUND: Secukinumab is a monoclonal antibody targeting interleukin-17A and is commonly used for managing autoimmune diseases such as, psoriasis, psoriatic arthritis, and ankylosing spondylitis. Prior studies have suggested that anti-IL17 therapy may worsen symptoms in patients with pre-existing...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Can Assoc Gastroenterol
Autors principals: Sarker, A, Shukla, T, Rostom, A, Sim, J, McCurdy, J D
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2021
Matèries:
Poster of Distinction
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7958707/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwab002.192
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars